Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
at-406 cellular inhibitor of apoptosis 1 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Lymphoma[MeSHID:D008223]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]		 13.64 phase 3 unknown
at-406 cellular inhibitor of apoptosis 1 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Lymphoma[MeSHID:D008223]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]		 13.64 phase 3 antagonist
at-406 cellular inhibitor of apoptosis 2 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Lymphoma[MeSHID:D008223]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]		 9.09 phase 3 unknown
at-406 cellular inhibitor of apoptosis 2 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Lymphoma[MeSHID:D008223]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]		 9.09 phase 3 antagonist
at-406 x-linked inhibitor of apoptosis protein NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Lymphoma[MeSHID:D008223]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]		 3.03 phase 3 unknown
at-406 x-linked inhibitor of apoptosis protein NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Lymphoma[MeSHID:D008223]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]		 3.03 phase 3 antagonist
click here to return to the previous page